Bucillamine use for rheumatoid arthritis and type 2 diabetes mellitus are associated with neural epidermal growth factor-like 1 (NELL1)-associated membranous nephropathy

Takahiro Tsuji, Sari Iwasaki, Keishi Makita, Shota Furukawa, Kanako Watanabe-Kusunoki, Sayo Takeda-Otera, Takahito Itoh, Mamiko Shimamoto, Hiroaki Yamaji, Tomomasa Yoshimura, Junya Yamamoto, Takashi Kudo, Makoto Kondo, Hiroshi Kataoka, Masaya Mukai, Yukito Kaga, Miku Yoshinari, Yuka Nishibata, Sakiko Masuda, Utano Tomaru, Akihiro Ishizu, Yuichiro Fukasawa, Seiji Hashimoto, Saori Nishio
doi: https://doi.org/10.1101/2022.12.02.22282616

Article Information

doi 
https://doi.org/10.1101/2022.12.02.22282616
History 
  • December 5, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Takahiro Tsuji, MD1,*,
  2. Sari Iwasaki, MD1,5,
  3. Keishi Makita, MD1,11,
  4. Shota Furukawa, MD2,9,
  5. Kanako Watanabe-Kusunoki, MD9,
  6. Sayo Takeda-Otera, MD2,
  7. Takahito Itoh, MD10,
  8. Mamiko Shimamoto, MD2,
  9. Hiroaki Yamaji, MD12,
  10. Tomomasa Yoshimura, MD13,
  11. Junya Yamamoto, MD14,
  12. Takashi Kudo, MD9,
  13. Makoto Kondo, MD3,
  14. Hiroshi Kataoka, MD3,
  15. Masaya Mukai, MD3,
  16. Yukito Kaga, BS4,
  17. Miku Yoshinari, MS4,8,
  18. Yuka Nishibata, BS8,
  19. Sakiko Masuda, PhD8,
  20. Utano Tomaru, MD6,
  21. Akihiro Ishizu, MD8,
  22. Yuichiro Fukasawa, MD1,
  23. Seiji Hashimoto, MD15 and
  24. Saori Nishio, MD7
  1. 1Department of Pathology, Sapporo City General Hospital, Hokkaido, Japan
  2. 2Department of Nephrology, Sapporo City General Hospital, Hokkaido, Japan
  3. 3Department of Rheumatology and Clinical Immunology, Sapporo City General Hospital, Hokkaido, Japan
  4. 4Department of Clinical Laboratory, Sapporo City General Hospital, Hokkaido, Japan
  5. 5Department of Pathology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan
  6. 6Department of Surgical Pathology, Hokkaido University Hospital, Hokkaido, Japan
  7. 7Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan
  8. 8Department of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Hokkaido, Japan
  9. 9Department of Internal Medicine, Kushiro Red Cross Hospital, Hokkaido, Japan
  10. 10Department of Cardiology, Oji General Hospital, Tomakomai, Hokkaido, Japan
  11. 11Department of Pathology, Oji General Hospital, Tomakomai, Hokkaido, Japan
  12. 12Department of Nephrology, Otaru General Hospital, Hokkaido, Japan
  13. 13Tomakomai Urology and Cardiology Clinic, Hokkaido, Japan
  14. 14Department of Nephrology, JCHO Hokkaido Hospital, Hokkaido, Japan
  15. 15Department of Nephrology, Kinan Hospital, Tanabe, Wakayama, Japan
  1. ↵*Corresponding Author:
    Takahiro Tsuji, Department of Pathology, Sapporo City General Hospital, North-11, West-13, Sapporo 060-8604, Japan Tel:+81-11-726-2211 / Fax:+81-11-726-9541, email: tsuji.takahiro{at}gmail.com
Back to top
Posted December 05, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Bucillamine use for rheumatoid arthritis and type 2 diabetes mellitus are associated with neural epidermal growth factor-like 1 (NELL1)-associated membranous nephropathy
Takahiro Tsuji, Sari Iwasaki, Keishi Makita, Shota Furukawa, Kanako Watanabe-Kusunoki, Sayo Takeda-Otera, Takahito Itoh, Mamiko Shimamoto, Hiroaki Yamaji, Tomomasa Yoshimura, Junya Yamamoto, Takashi Kudo, Makoto Kondo, Hiroshi Kataoka, Masaya Mukai, Yukito Kaga, Miku Yoshinari, Yuka Nishibata, Sakiko Masuda, Utano Tomaru, Akihiro Ishizu, Yuichiro Fukasawa, Seiji Hashimoto, Saori Nishio
medRxiv 2022.12.02.22282616; doi: https://doi.org/10.1101/2022.12.02.22282616
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area